Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2025-12-27 @ 11:34 PM
Study NCT ID:
NCT03879460
Status:
COMPLETED
Last Update Posted:
2019-05-17
First Post:
2019-03-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Evaluation of Safety and Tolerance of Commercially Available Naltrexone Administered Daily - Assessment for CBRN Operations
Sponsor:
Timothy Smith
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03-18
Start Date Type:
ACTUAL
Primary Completion Date:
2019-03-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-03-31
Completion Date Type:
ACTUAL
First Submit Date:
2019-03-14
First Submit QC Date:
None
Study First Post Date:
2019-03-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-05-15
Last Update Post Date:
2019-05-17
Last Update Post Date Type:
ACTUAL